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Dear colleagues,
The current issue of the European Archives of Psychiatry
and Clinical Neuroscience offers a selection of key topics
currently discussed in psychiatric research ranging from
neurobiological ﬁndings to population-based as well as
proof of principle studies.
The term ‘‘biomarkers’’ is often not used properly in
neuroscience as pointed out in the Letter to the Editors by
Martins-de-Souza [1]. As outlined in this short article, there
is an explosion of the term ‘‘biomarker’’, which is often
used for ‘‘a differentially expressed’’ protein discovered as
potentially related to some disease in a small sample. The
author suggests to be more cautious when using this term
and instead suggests to use ‘‘potential biomarkers’’ or
‘‘biomarker candidate’’ as a better and clearer name.
One of those ﬁelds with potential new biomarkers is the
epidemiology of psychoses. Related to that, Steiner et al.
[2] describe in their well-designed paper that in acute
paranoid schizophrenia, there might well be reduced T-cell
defense and a shift toward B-cell immunity, which nor-
malizes in the response to treatment. Importantly, they
point out that in addition to the disease stage or subtype of
the illness medication, cigarette smoking and stress are
important co-factors.
Researching cognitive dysfunction in schizophrenia has
moved to test circuit-speciﬁc tasks in this disorder. The
paper by Zilles et al. [3] moves this way identifying sub-
groups of patients with schizophrenia showing different
patterns of selective deﬁcits in working memory compo-
nents. These deﬁcits are present in tasks requiring only the
maintenance of verbal or visuospatial information. In
contrast to an obviously global working memory deﬁcit,
individual analysis revealed differential patterns of work-
ing memory impairments in subgroups of patients with
schizophrenia.
Trying to connect brain changes in major psychiatric
disorders like depression with pathophysiological mecha-
nisms is desired but difﬁcult. Candidates for hippocampal
volume reduction in depressed patients are the neurotro-
phic factors. Along these lines, Eker et al. [4] found
a correlation of serum BDNF levels with hippocampal
volumes in ﬁrst-episode, medication-free depressed
patients. This correlation could not be revealed in the
control sample, and more interestingly, there was no sig-
niﬁcant volumetric difference between the depressed
patients and the control subjects pointing to a very subtle
volumetric change related to BDNF secretion.
Subsequently, two studies were selected using large
samples of healthy subjects. In the ﬁrst study by Moraes
et al. [5], the mini-mental state examination (MMSE) was
applied in a sample of 2,708 adults, aged 60 years and
older. High scores on a depression scale, high scores on a
memory complaints scale and low socioeconomic levels
were associated with poorer performance on the MMSE.
This underlines the importance of some sociodemographic
and health variables inﬂuencing MMSE performance and
furthermore pointing at the increasingly important trajec-
tory between mood disorder and the later development of
dementia.
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DOI 10.1007/s00406-010-0154-6In the second study by Brand et al. [6], 862 participants
completed a series of validated self-report questionnaires
assessing sleep, quality of life, depressive symptoms and
cognitive-emotional elaboration of pain. For this non-
clinical sample of young adults, the bi-directional relation
between poor sleep and increased cognitive-emotional
elaboration of pain was proven.
In an open proof of principle study by Perugi et al. [7], it
was tested whether adjunctive valproate treatment might
ameliorate panic disorder symptoms with a lifetime
comorbid bipolar disorder or patients otherwise resistant to
antidepressants. All patients were evaluated baseline and at
least every three month and followed for a period of three
years. According to the results, valproate seems to be an
effective and a well-tolerated adjunctive treatment in panic
disorder patients who are resistant to antidepressant ther-
apy or have bipolar disorders in comorbidity. This supports
the hypothesis that the resistance to antidepressants might
well be related to mood instability.
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